Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q98945332
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010743.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q98945332
|
024
|
|
|
‡a
0000-0002-8625-6351
‡2
orcid
|
024
|
|
|
‡a
35509636200
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q98945332
|
100
|
0 |
|
‡a
Lidia Moreira Lima
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Lidia Moreira Lima
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease
|
670
|
|
|
‡a
Author's Design, Synthesis, Antinociceptive and Anti-Inflammatory Activities of Novel Piroxicam Analogues
|
670
|
|
|
‡a
Author's Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs
|
670
|
|
|
‡a
Author's New Benzofuran N-Acylhydrazone Reduces Cardiovascular Dysfunction in Obese Rats by Blocking TNF-Alpha Synthesis
|
670
|
|
|
‡a
Author's Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity
|
909
|
|
|
‡a
(orcid) 0000000286256351
‡9
1
|
909
|
|
|
‡a
(scopus) 35509636200
‡9
1
|
919
|
|
|
‡a
preclinicalevaluationoflassbio1491frominvitropharmacokineticstudytoinvivoleishmanicidalactivity
‡A
Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity
‡9
1
|
919
|
|
|
‡a
assessmentoftheinvivogenotoxicityofnewleadcompoundstotreatsicklecelldisease
‡A
Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease
‡9
1
|
919
|
|
|
‡a
designsynthesisantinociceptiveandantiinflammatoryactivitiesofnovelpiroxicamanalogues
‡A
Design, Synthesis, Antinociceptive and Anti-Inflammatory Activities of Novel Piroxicam Analogues
‡9
1
|
919
|
|
|
‡a
discoveryofputativedualinhibitoroftubulinandegfrbyphenotypicapproachonlassbio1586homologs
‡A
Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs
‡9
1
|
919
|
|
|
‡a
newbenzofurannacylhydrazonereducescardiovasculardysfunctioninobeseratsbyblockingtnf Alpha synthesis
‡A
New Benzofuran N-Acylhydrazone Reduces Cardiovascular Dysfunction in Obese Rats by Blocking TNF-Alpha Synthesis
‡9
1
|
996
|
|
|
‡2
PLWABN|9811563124105606
|
996
|
|
|
‡2
BLBNB|000259014
|
996
|
|
|
‡2
NUKAT|n 2013053440
|
996
|
|
|
‡2
NTA|314606807
|
996
|
|
|
‡2
DNB|1170443265
|
996
|
|
|
‡2
PTBNP|78249
|
996
|
|
|
‡2
ISNI|000000039689918X
|
996
|
|
|
‡2
PLWABN|9812080106705606
|
996
|
|
|
‡2
DNB|137013795
|
996
|
|
|
‡2
LC|no2015103465
|
996
|
|
|
‡2
DNB|1044197862
|
996
|
|
|
‡2
BLBNB|000597366
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|